Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002;3(3):E21.
doi: 10.1208/pt030321.

A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells

Affiliations

A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells

Bhas A Dani et al. AAPS PharmSciTech. 2002.

Abstract

The purpose of this study was to evaluate salmon calcitonin (sCT) microspheres in vitro for their antiresorptive activity using cultured osteoclastic cells. The antiresorptive activity of sCT-loaded microspheres, prepared from a low molecular weight hydrophilic poly (lactide-co-glycolide) polymer (PLGA), was studied using bone marrow culture cells harvested from juvenile rats and cultured on slices of devitalized bone for up to 4 weeks. The resorptive activity of osteoclastic cells was quantified in terms of number and type of resorption pits and total area of resorption. Microspheres containing 5.1% sCT released 70% peptide in 2 weeks and 88% in 4 weeks. All sCT treatments inhibited total resorptive activity. A dose-dependent decrease in resorption was observed with sCT microspheres at 2 weeks. The high dose (10 mg of microspheres) produced a 99.5% decrease in resorption at 3 weeks, while the low dose (1 mg) produced an 80% reduction. Exposure of cultures to soluble sCT and sCT-loaded microspheres caused a decrease in the number of large pits, which were the predominant type formed in control cultures. Thus, this system could serve as an in vitro method to evaluate the antiresorptive effect of PLGA-sCT microspheres.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Chambers TJ, Moore A. The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab. 1983;57:819–824. doi: 10.1210/jcem-57-4-819. - DOI - PubMed
    1. Milhaud G. Etude du mecanisme de l'action hypocalcemiante de la thyrocalcitonine. CR Acad Sci Paris. 1965;261:813–816. - PubMed
    1. Martin TJ, Robinson CJ, Maclntyre I. The mode of action of thyrocalcitonin. Lancet. 1966;1:900–902. doi: 10.1016/S0140-6736(66)91577-7. - DOI - PubMed
    1. Kohler H. Wechselwirkung von Thyreocalcitonin und Parathormon. Schweiz med Wochenschr. 1968;98:728–728. - PubMed
    1. Munson PL. Physiology and pharmacology of thyrocalcitonin. In: Aurbach GD, editor. Handbook of Physiology. Washington, DC: American Physiological Society; 1976. pp. 443–464.

Publication types

MeSH terms

LinkOut - more resources